Jump to navigation
STEM CELLS | STEM CELLS Translational Medicine
A new trial evaluates the therapeutic potential of sibling cord blood as a safe and effective treatment for cerebral palsy
Researchers report on the administration of sibling umbilical cord blood infusions in fifteen children with cerebral palsy
Researchers describe an optimized process for the isolation of EVs from UCB‐MNCs that may allow for their widespread therapeutic use as a means to enhance wound healing
Cord blood‐derived ILCs are distinct from circulating ILCs in adults and tissue‐resident ILCs
A report identifies the main technical procedures currently used by public cord blood banks worldwide
Researchers report a crucial role for mTOR in cell‐cycle progression and proliferation in the commitment/proliferation phase of erythropoiesis
For the past 30 years, umbilical cord blood has been a viable graft source option for hematopoietic cell transplant for both pediatric and adult patients with hematologic disorders.
The limited numbers of cord blood hematopoietic stem cells (HSCs) collected at birth remains a critical limiting factor in the use of cord blood for HSC transplantation.
A new STEM CELLS Translational Medicine article from researchers led by
A recent STEM CELLS article from researchers led by
The Stem Cells Portal is a shared platform for the STEM CELLS and STEM CELLS Translational Medicine sister journals, providing up-to-the-minute coverage of the latest research from bench science and developments to clinical applications.
Copyright © 2021